Post-mastectomy benign lymphangioendothelioma of the skin following chronic lymphedema for breast carcinoma: a teaching case mimicking low-grade angiosarcoma and masquerading as Stewart-Treves syndrome by unknown
Yamada et al. Diagnostic Pathology 2014, 9:197
http://www.diagnosticpathology.org/content/9/1/197CASE REPORT Open AccessPost-mastectomy benign lymphangioendothelioma
of the skin following chronic lymphedema for
breast carcinoma: a teaching case mimicking
low-grade angiosarcoma and masquerading as
Stewart-Treves syndrome
Sohsuke Yamada1*, Yoko Yamada2, Miwa Kobayashi2, Ryosuke Hino2, Aya Nawata1, Hirotsugu Noguchi1,
Motonobu Nakamura2 and Toshiyuki Nakayama1Abstract
Benign lymphangioendothelioma (BL) represents a very rare lymphatic vascular proliferation. Our aim is to be aware
that owing to its characteristic features, pathologists can easily misinterpret it as cutaneous low-grade angiosarcoma
when examining only small specimens. In the present case, multiple small and yellowish to reddish soft nodules
were noticed in the edematous left arm of a 54-year-old Japanese female 4 years after the radical mastectomy with
axillary lymph nodes dissection and following radiotherapy to the chest for the left breast carcinoma. The biopsy
specimen showed an ill-defined lesion composed of a proliferation of irregular and sometimes anastomosing vascular
structures in the dermis, lined by endothelial cells having mildly hyperchromatic and pleomorphic nuclei, but no
mitotic figures. As the lesion grew within deeper dermis, these proliferating vessels dissected dermal collagenous
bands, occasionally arranged in low-papillary projections and/or characteristic hobnail cytomorphology. We first
interpreted it as low-grade angiosarcoma following chronic lymphedema due to the operation, i.e., the so-called
Stewart-Treves syndrome. Although additional treatments were performed for 7 years, she had neither local invasion
nor metastases of these tumors, respectively, and was alive and well. Retrospective immunohistochemical findings
demonstrated that these mildly atypical endothelial cells were strongly positive for lymphatic vessel endothelial
hyaluronan receptor (LYVE)-1 as well, and MIB-1 labeling index was less than 1%. Therefore, we finally made a
diagnosis of BL of the skin. MIB-1 labeling index might be useful and adjunctive aids for reaching the correct
diagnosis of cutaneous BL, especially in case of small or inadequate specimens.
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Among all sarcomas, angiosarcomas are rare, accounting
for merely less than 1% [1]. Enzinger and Weiss have
classified them as follows: (a) cutaneous angiosarcoma
associated with lymphedema; (b) cutaneous angiosar-
coma unassociated with lymphedema; (c) angiosarcoma
of the breast; and (d) angiosarcoma of deep soft tissue
[1]. Intriguingly, about 90% of all (a) angioosarcomas asso-
ciated with chronic lymphedema occur after mastectomy
for breast cancer [1,2]. Actually, Stewart and Treves first
reported the development of angiosarcoma arising on
longstanding lymphedematous extremities, due to axillary
lymph nodes dissection following a radical mastectomy,
named as the so-called Stewart-Treves syndrome, in 1948
[3]. Clinically, this disease is characterized by red to blue
and firm nodules and/or plaques on the affected extrem-
ities [2,3]. To date, more than 400 cases of Stewart-Treves
syndrome have been described in the literature, and the
patients have a very poor prognosis, complicated with re-
currence, distant metastases, and very early death within
2 years [3,4]. It is also noteworthy that the prevalence is
estimated at about 0.45% in patients with Stewart-Treves
syndrome who survive longer than post-operative 5 years
[4], and in fact, that very few long-term survivors have
been recognized [1,2].
By contrast, among the lymphatic neoplasms, benign
lymphangioendothelioma (BL) represents a very rare
lymphatic vascular proliferation, histopathologically mim-
icking other malignant vascular neoplasms, such as
cutaneous low-grade angiosarcoma, and readily mis-
diagnosed as it [5]. BL, also named as acquired pro-
gressive lymphangioma, was first described by Wilson
Jones et al. in 1990 [6,7], and only 40 cases have been re-
ported in the English-language literature [7,8]. Clinically,
a typical lesion is a solitary and well-circumscribed
red or bruise-like macule, plaque or nodule, which can
be variably located on the breast, arm, face, scalp, or thigh
[5-8]. BL has a tendency to present in middle-aged to
elderly adults and particularly evolve slowly over years
[5,7,8]. Moreover, the BL lesions are usually asymptom-
atic but occasionally have a predisposing factor, e.g., radio-
therapy, trauma, arteriography, or tick bite [8]. One of the
most important differential diagnosis is with low-grade
angiosarcoma, since BL shares with angiosarcoma the
histopathological presence of extensive dissection of colla-
gen bundles [5,8]. Thus, it is critical to establish an accur-
ate initial diagnosis whether benign or malignant by
biopsy specimens, however, previous studies have indi-
cated the somewhat difficulties of correct characterization
of BL [8,9].
We report an extremely rare case of post-mastectomy
cutaneous BL following chronic lymphedema, easily con-
fused with low-grade angiosarcoma, so-called Stewart-
Treves syndrome.Materials and methods
The patient was a 45-year-old Japanese woman. The
time interval from the first and follow-up biopsy was
7 years. The tumor biopsy specimens after fixation in
10% neutral buffered formalin were embedded in paraf-
fin for histological or immunohistochemical examina-
tions. We counted the number of proliferating lymphatic
vessels in 10 randomly selected fields of not only tumor
but non-tumor areas per section (original magnification:
×400) [10,11]. All immunohistochemical stainings were
carried out using Dako Envision kit (Dako Cytomation
Co., Glostrup, Denmark) according to the manufac-
turer’s instructions. 1]. Furthermore, the distribution of
the staining with MIB-1 (Ki67; DAKO) in the tumor was
assessed semi-quantitatively, counted at high power (ori-
ginal magnification: ×400) magnification. At least 1,000
nuclei were counted in each section. The MIB-1 labeling
index was presented as number of positive nuclei per
1,000 nuclei counted [12].
All histological and immunohistochemical slides were
evaluated by two independent observers (certified surgi-
cal pathologists in our department) [10-12]. Agreement
between observers was excellent (>0.9) for all antibodies
investigated as measured by interclass correlation coeffi-
cient. For the few instances of disagreements, a consensus
score was determined by the third board-certified patholo-
gists in our department [10-12].
All values are expressed as the means ± SE. Significant
differences were analyzed using Student’s t-test. Values
of P <0.05 were considered to be statistically significant.
Case presentation
Clinical summary
The patient had a history of left breast carcinoma, diag-
nosed as invasive ductal carcinoma but unknown de-
tailed histological features, 4 years ago. She underwent a
radical mastectomy with axillary lymph nodes dissection
and following radiotherapy to the chest for it. There was
no history of immunosuppressive disorders, use of im-
munosuppressive medications, or unusual infections, in-
cluding acquired immunodeficiency syndrome (AIDS).
She suffered from chronic lymphedema of the left arm
supervened shortly after the operation (Figure 1A) and
noticed multiple small and yellowish to reddish soft nod-
ules, measuring up to 6 mm in the edematous left arm
(Figure 1B). Since the number of those lesions was grad-
ually increasing, a biopsy was performed. Moreover,
interleukin-2 immunotherapy, additional radiotherapy (to
the chest) and adjuvant chemotherapy using low-dose do-
cetaxel were done for post-operative 7 years, under the
initial diagnosis of low-grade angiosarcoma following
longstanding lymphedema due to the radical mastectomy
with axillary lymph nodes dissection for the breast carcin-
oma, i.e., the so-called Stewart-Treves syndrome, based on
Figure 1 Clinical finding of this BL. (A, B) The patient suffered from chronic lymph edema of the affected left arm supervened shortly after the
radical mastectomy with axillary lymph nodes dissection (A) and noticed multiple small and yellowish to reddish soft nodules (A, arrows), measuring
up to 6 mm in the edematous left arm (B). The number of those lesions was gradually increasing up. Bar = 10 mm.
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cluding blood cell count and chemistry, were within nor-
mal limits, except for modestly high level of hemoglobin
A1c (HbA1c; 6.1 mg/dL), and there was no evidence
of tumor or tumor-like lesions in the CT scannings of
chest and abdomen. Anti-human immunodeficiency virus
(HIV) antibodies were completely negative. Within the
post-operative 7 years with additional treatment of
interleukin-2 immunotherapy and chemo-radiotherapy,
partial remission and neogenesis of the above small nod-
ules were repeatedly seen. Very surprisingly, the patient
had neither local invasion nor metastases of these lesions,
respectively, and was alive and well at 5 years after the
final chemotherapy. Furthermore, other skin lesions in-
cluding those at the mastectomy site have never appeared.
Pathological findings
The first small biopsy specimen (Figure 2A) showed an
ill-defined lesion predominantly composed of a signifi-
cant proliferation of irregular and sometimes anastomos-
ing vascular structures containing no red blood cells
mostly in the middle to lower layer of dermis (tumor:
24.5 ± 2.9 per 1 high power fields vs. non-tumor: 2.7 ±
0.4 per 1 high power fields; P <0.0001) (Figure 2A). Fewlesions involve the superficial dermis, and extension into
the subcutaneous fat was absent (Figure 2A). These vas-
cular channels were lined by modestly atypical endothe-
lial cells having mildly hyperchromatic and pleomorphic
nuclei, but no apparent mitotic figures (Figure 2B). As
the lesion grew within deeper dermis, these proliferating
vascular channels dissected dermal collagenous bundles,
occasionally arranged in low-papillary projections and/or
characteristic hobnail or multi-layered cytomorphology
(Figure 2B). Surrounding lymphocytic infiltrate was not
evident. On the other hand, the covering epidermis ex-
hibited mild acanthosis and modestly elongated thick-
ened rete ridge without any evidence of atypical changes
(Figure 2A). Based on these features, we first diagnosed
it as low-grade angiosarcoma following chronic lymph-
edema due to the radical mastectomy, i.e., the so-called
Stewart-Treves syndrome. However, the follow-up biopsy
specimens from the affected left arm demonstrated no evi-
dence of any remarkable changes on histopathological
findings, very similar to those of the above first biopsy
sample. Immunohistochemically, these proliferating endo-
thelial cells were positive for CD31 (DAKO, diluted 1:20)
(Figure 3A), factor VIII-related antigen (DAKO, diluted
1:30), CD34 (IMMUNOTECH, Marseille, France, diluted
Figure 2 Microscopic examination of the first biopsy specimen. (A) The first small biopsy specimen (H&E stains, inset) revealed an ill-defined
lesion predominantly composed of a proliferation of irregular and sometimes anastomosing vascular structures containing no red blood cells
mostly in the middle to lower layer of edematous dermis. Few lesions involve the superficial dermis, and extension into the subcutaneous fat was
absent (inset). The covering epidermis exhibited mild acanthosis and modestly elongated thickened rete ridge without any evidence of atypical
changes (H&E stains). Bars =1 mm. (B) On high-power view (H & E stains), these vascular channels were lined by modestly atypical endothelial
cells having mildly hyperchromatic and pleomorphic nuclei, but no apparent mitotic figures. As the lesion grew within deeper dermis, these
proliferating vascular channels dissected dermal collagenous bundles, occasionally arranged in low-papillary projections (inset) and/or characteristic
hobnail or multi-layered cytomorphology (inset). Surrounding lymphocytic infiltrate was not evident. Bar = 200 μm.
Yamada et al. Diagnostic Pathology 2014, 9:197 Page 4 of 7
http://www.diagnosticpathology.org/content/9/1/1971:50), and Podoplanin (D2-40; Nichirei Bioscience Co., Tokyo,
Japan, diluted 1:1) on the first biopsy specimen. Further-
more, the tumor cells of both the first and follow-up
biopsy specimens showed strong immunohistochemi-
cal expression of lymphatic vessel endothelial hyaluronan re-
ceptor (LYVE)-1 (LYVE-1; R&D Systems, Inc., Minneapolis,
MN, USA, diluted 1:320) (Figure 3A) and lower MIB-1
(Ki67; DAKO, diluted 1:50) labeling index, less than 1%
(0.3%) (Figure 3B). There was no immunohistochemical
expression of human herpes virus (HHV)-8 (HHV-8; Santa
Cruz Biotechnology, Santa Cruz, CA, USA, diluted 1:100).
Therefore, we confirmed that these mildly proliferatingendothelial cells were derived from lymphatic vessels, and
finally made a diagnosis of post-mastectomy BL of the
skin following chronic lymphedema, based on the clinico-
pathological findings including its unusually benign clin-
ical course.
Discussion
The most important differential diagnosis in the present
BL case is with a low-grade angiosarcoma following post-
mastectomy chronic lymphedema, i.e., the so-called
Stewart-Treves syndrome. Clinically, the average time
between radical mastectomy and angiosarcoma progression
Figure 3 Immunohistochemical examination of the first biopsy specimen. (A) These modestly atypical endothelial cells were positive for
CD31, but strongly positive for LYVE-1. (B) The tumor cells showed a much lower MIB-1 labeling index, less than 1%. Bars =50 μm.
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as red-blue firm nodules, plaques, blood blisters or ulcer
formation, usually in the background of more than
10-years lymphedema [1,2], unlike the present case. In
addition, extremely rare long-term survivors with Stewart-
Treves syndrome are reported to have early amputa-
tion of the affected extremity [2]. Our case actually showed
neither local invasion nor metastases within the post-
operative 7 years with additional treatment of immuno-
therapy and adjuvant chemo-radiotherapy, but was also
alive and well at 5 years after the final chemotherapy,
manifesting as overtly benign clinical behavior. In con-
trast, BL occurring in a patient with chronic lymphedema
after mastectomy is much rarer than Stewart-Treves syn-
drome. Indeed, although an extraordinary case of BL in a
48-year old woman is reported, appearing in the breast
skin close to a mastectomy scar 3 years after surgery forinvasive ductal carcinoma, the authors have never referred
to chronic lymphedema [13]. Since it remains unclear
whether the chronic lymedema is a predisposing factor for
the BL lesions [8], further studies are thus needed to ad-
dress the disease developing mechanism after collecting
and investigating a much larger number of BL cases clini-
copathologically examined. In fact, more recently, there
have been some evidences about that BL is not a true neo-
plasm but rather a lymphatic vascular malformation by
reason of the absence of Wilms tumor 1 (WT-1) expres-
sion [14]. BL occasionally presents as multiple nodular
and/or papular lesions, as in the current case not only
synchronous but metachronous [5,13]. In this context, we
for the first time report an extremely rare case of post-
mastectomy cutaneous BL following chronic lymphedema
in the affected arm, easily confused with low-grade angio-
sarcoma, so-called the Stewart-Treves syndrome.
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nosis as suspicious or suggestive of low-grade angiosarcoma.
As shown in Figure 2, BL is characterized by the presence of
irregular, tortuous and anastomosing endothelial-lined
vessels, showing hobnail cytomorphology, and dissecting
between dermal collagen bundles as the lesion permeates
the deep dermis, similar to invasive features of malignant
neoplasms. Moreover, it is possible that a small amount of
the biopsy specimen further results in the misdiagnosis of
a malignant angiosarcoma-like lesion. A tentative diagno-
sis of vascular tumor with malignant potential should be
borne in mind at the very least, whenever pathologists en-
counter dermal collection of vascular vessels with an inva-
sive growth pattern. However, in addition to the suspicion
of no clinical malignancy, a detailed histopathological
study can retrospectively reveal that the vascular channels
usually devoid of red blood cells display neither cellular
nor poorly differentiated areas, and that the lining endo-
thelial cells have mild cellular atypia with absence of prom-
inent nuclear pleomorphism or mitotic figures [5-9,13], as
presented here. By contrast, we propose that the MIB-1 la-
beling index should be a useful and adjunctive aid for BL
to distinguish from low-grade angiosarcoma, as well as the
number of mitoses or highly atypical cells. Even a small
amount of the biopsy specimen demonstrated a very low
(less than 1%) MIB-1 positivity (Figure 3B), corresponding
to the few previous immunohistochemical studies of BLs
[13]. Further investigation with more clinicopathological
samples of cutaneous BL, is necessary to confirm the
importance of this well-known proliferative indicator.
Nevertheless, since the primary biopsy sampling in the
current case was adequate, BL of the skin might not be
problematic for one of the initial differential diagnoses.
Furthermore, the above clinically good course plus patho-
logically modestly atypical tumor cells seem to provide
enough information for pathologists to recommend care-
ful follow-up but not additional treatments.
Among malignant to benign tumors, histopathologically
differential diagnoses include vascular vessel proliferations
in the dermis, such as patch-stage Kaposi’s sarcoma, reti-
form hemangioendothelioma, lymphangioma circumscrip-
tum, or lymphangiomatous papules of the skin, respectively
[2,5-9,13]. Immunohistochemical analyses partly resolve the
distinction from the first Kaposi’s sarcoma easily, since
Kaposi’s sarcoma is often identified in HIV-infected pa-
tients and is usually positive for HHV-8 [14], unlike in the
present case. Furthermore, strong immunohistochemical
expression of antibody against novel lymphatic marker,
LYVE-1 (Figure 3A), might allow discrimination of BL
from malignant vascular tumors [15], although it will be
intriguing to see whether LYVE-1 immunoexpression pat-
tern have reliable roles in this regard. However, it is also
important to histologically recognize concomitant lym-
phoplasmacytic or lymphocytic infiltration of the dermalinterstitium in Kaposi’s sarcoma or retiform hemangioen-
dothlioma, in contrast to BL [1,9]. As to the benign
lymphatic vessels proliferation, including lymphangioma
circumscriptum or lymphangiomatous papules, the fea-
tures of hobnail morphology and/or anastomosing or pap-
illary structures are never as specific or pronounced as
those observed in BL [5-9,13,14]. In fact, lymphangioma is
predominantly composed of numerous dilated but not
irregular-shaped lympatic vessels [5-9,13].
Conclusion
We reported an extremely rare case of post-mastectomy
BL of the skin following chronic lymphedema, histopatho-
logically mimicking low-grade angiosarcoma and mas-
querading as the so-called Stewart-Treves syndrome. The
present case was tentatively misdiagnosed as malignancy
on the examination of the first biopsy specimen, since its
section showed an ill-defined lesion composed of a prolif-
eration of irregular and sometimes anastomosing vascular
structures lined by mildly atypical endothelial cells. Add-
itionally, these proliferating vessels dissected dermal col-
lagenous bundles in the middle to lower layer of dermis,
as the lesion grew within deeper dermis, arranged in low-
papillary projections and/or characteristic hobnail cyto-
morphology. All pathologists should be aware that its
characteristic features could easily lead to a misdiagnosis
of low-grade angiosarcoma. Furthermore, we suggest that
MIB-1 labeling index might be useful and adjunctive aids
for recognizing no evidence of malignancy and reaching
the correct diagnosis of cutaneous BL, as well as mod-
estly atypical lining endothelial cells with mildly pleo-
morphic nuclei, but no apparent mitotic figure, especially
in case of small or inadequate specimens. In this context,
the present case report should interest the scientific com-
munity, taken together with new immunohistochemical
findings and specific recommendations for diagnostic
pathology.
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